Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Non Operating Income (2016 - 2020)

Historic Non Operating Income for Niagen Bioscience (NAGE) over the last 12 years, with Q2 2020 value amounting to -$24000.0.

  • Niagen Bioscience's Non Operating Income rose 9582.61% to -$24000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was -$343000.0, marking a year-over-year increase of 3491.46%. This contributed to the annual value of -$847000.0 for FY2019, which is 48819.44% down from last year.
  • Latest data reveals that Niagen Bioscience reported Non Operating Income of -$24000.0 as of Q2 2020, which was up 9582.61% from -$12000.0 recorded in Q1 2020.
  • Over the past 5 years, Niagen Bioscience's Non Operating Income peaked at $746000.0 during Q3 2017, and registered a low of -$575000.0 during Q2 2019.
  • Over the past 5 years, Niagen Bioscience's median Non Operating Income value was -$28000.0 (recorded in 2017), while the average stood at -$64511.5.
  • In the last 5 years, Niagen Bioscience's Non Operating Income surged by 26636.34% in 2017 and then plummeted by 338888.89% in 2019.
  • Quarter analysis of 5 years shows Niagen Bioscience's Non Operating Income stood at -$18360.0 in 2016, then crashed by 139.83% to -$44033.0 in 2017, then soared by 149.96% to $22000.0 in 2018, then plummeted by 68.18% to $7000.0 in 2019, then tumbled by 442.86% to -$24000.0 in 2020.
  • Its Non Operating Income stands at -$24000.0 for Q2 2020, versus -$12000.0 for Q1 2020 and $7000.0 for Q4 2019.